Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Pain, Postoperative 10 Colorectal Neoplasms 10 Neoplasms 8 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Hemorrhage 4 Head and Neck Neoplasms 4 Agnosia 4 Rectal Neoplasms 3 Neurotoxicity Syndromes 3 Nasopharyngeal Carcinoma 3 Myoma 3 Multiple Endocrine Neoplasia Type 1 3 Meningioma 3 Lymphoma, Non-Hodgkin 3 Leiomyoma 3 Glioblastoma 3 Delirium 3 Colonic Neoplasms 3 Chronic Pain 3 Warts 2 Uterine Cervical Neoplasms 2 Stomatitis 2 Skin Neoplasms 2

Interventions

Ketamine 3 Morphine 2 Methadone 2 Dexmedetomidine 2 ziconotide 1 substance P-saporin 1 Sodium Chloride 1 Ropivacaine 1 Registries 1 Passive Cutaneous Anaphylaxis 1 Midazolam 1 Lidocaine 1 Infusion Pumps, Implantable 1 Hydromorphone 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain, Intractable × Sodium Chloride × Clear all

NCT01951911 2017-07-11

KETA-1

Haukeland University Hospital

Phase 3 Withdrawn

Agnosia, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡